Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension | 11 | 2022 | 796 | 4.060 |
Why?
|
| Antioxidants | 18 | 2023 | 416 | 3.310 |
Why?
|
| Oxidative Stress | 18 | 2023 | 938 | 2.890 |
Why?
|
| Kidney | 13 | 2022 | 337 | 2.130 |
Why?
|
| Rats, Wistar | 15 | 2023 | 233 | 1.980 |
Why?
|
| Antihypertensive Agents | 6 | 2020 | 284 | 1.930 |
Why?
|
| Rats | 26 | 2023 | 3483 | 1.890 |
Why?
|
| Endothelin-1 | 9 | 2007 | 55 | 1.690 |
Why?
|
| Luteolin | 3 | 2021 | 9 | 1.640 |
Why?
|
| Sodium Fluoride | 7 | 2022 | 9 | 1.630 |
Why?
|
| NF-E2-Related Factor 2 | 3 | 2021 | 77 | 1.570 |
Why?
|
| Blood Pressure | 9 | 2022 | 646 | 1.530 |
Why?
|
| Animals | 50 | 2023 | 15081 | 1.370 |
Why?
|
| Dietary Supplements | 3 | 2022 | 208 | 1.370 |
Why?
|
| Vasodilation | 8 | 2016 | 65 | 1.340 |
Why?
|
| Plant Extracts | 5 | 2023 | 286 | 1.300 |
Why?
|
| Heart | 4 | 2018 | 180 | 1.290 |
Why?
|
| Azadirachta | 2 | 2018 | 3 | 1.250 |
Why?
|
| Endothelium, Vascular | 5 | 2012 | 237 | 1.230 |
Why?
|
| Gallic Acid | 2 | 2018 | 15 | 1.220 |
Why?
|
| Protective Agents | 4 | 2018 | 25 | 1.060 |
Why?
|
| Flavanones | 2 | 2023 | 8 | 0.970 |
Why?
|
| Signal Transduction | 7 | 2020 | 1908 | 0.970 |
Why?
|
| Clofibrate | 3 | 2021 | 13 | 0.950 |
Why?
|
| Cerebrovascular Circulation | 6 | 2002 | 70 | 0.900 |
Why?
|
| Kidney Diseases | 2 | 2022 | 167 | 0.890 |
Why?
|
| Lisinopril | 1 | 2022 | 4 | 0.880 |
Why?
|
| Rutin | 2 | 2020 | 3 | 0.850 |
Why?
|
| Vasodilator Agents | 7 | 2012 | 56 | 0.850 |
Why?
|
| Nitric Oxide | 7 | 2022 | 316 | 0.850 |
Why?
|
| PPAR alpha | 3 | 2021 | 42 | 0.810 |
Why?
|
| Apoptosis | 2 | 2020 | 1398 | 0.790 |
Why?
|
| Ramipril | 1 | 2020 | 4 | 0.760 |
Why?
|
| Renin | 1 | 2020 | 30 | 0.750 |
Why?
|
| Sodium Compounds | 2 | 2017 | 11 | 0.750 |
Why?
|
| Doxorubicin | 2 | 2018 | 84 | 0.740 |
Why?
|
| Protein Kinase C | 4 | 2010 | 120 | 0.740 |
Why?
|
| NF-kappa B | 3 | 2020 | 339 | 0.740 |
Why?
|
| Dental Caries | 1 | 2021 | 57 | 0.730 |
Why?
|
| Arsenites | 2 | 2017 | 51 | 0.710 |
Why?
|
| Zinc | 1 | 2021 | 128 | 0.700 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 169 | 0.700 |
Why?
|
| Hematoma | 5 | 1997 | 16 | 0.690 |
Why?
|
| Male | 23 | 2023 | 20025 | 0.690 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 123 | 0.680 |
Why?
|
| Aorta | 3 | 2012 | 167 | 0.680 |
Why?
|
| Vasoconstrictor Agents | 4 | 2005 | 41 | 0.660 |
Why?
|
| Quercetin | 1 | 2018 | 45 | 0.620 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 140 | 0.620 |
Why?
|
| Arsenic Poisoning | 1 | 2017 | 6 | 0.610 |
Why?
|
| Sodium Chloride, Dietary | 2 | 2016 | 41 | 0.610 |
Why?
|
| Receptors, Mineralocorticoid | 3 | 2022 | 11 | 0.590 |
Why?
|
| Hindlimb | 2 | 2016 | 27 | 0.580 |
Why?
|
| Vitamin E | 1 | 2017 | 61 | 0.580 |
Why?
|
| Vasoconstriction | 8 | 2016 | 42 | 0.570 |
Why?
|
| Cariostatic Agents | 1 | 2016 | 4 | 0.570 |
Why?
|
| Orchiectomy | 1 | 2016 | 35 | 0.570 |
Why?
|
| Vascular Resistance | 1 | 2016 | 34 | 0.560 |
Why?
|
| Superoxide Dismutase | 4 | 2018 | 155 | 0.520 |
Why?
|
| Testosterone | 1 | 2016 | 193 | 0.520 |
Why?
|
| Reactive Oxygen Species | 2 | 2016 | 461 | 0.520 |
Why?
|
| Up-Regulation | 1 | 2018 | 513 | 0.510 |
Why?
|
| Cell Adhesion Molecules | 3 | 2020 | 75 | 0.510 |
Why?
|
| Phenylephrine | 3 | 2016 | 36 | 0.510 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 269 | 0.500 |
Why?
|
| Swine | 12 | 2006 | 184 | 0.490 |
Why?
|
| Glutathione | 4 | 2018 | 179 | 0.480 |
Why?
|
| Liver | 4 | 2023 | 479 | 0.470 |
Why?
|
| Malondialdehyde | 3 | 2018 | 41 | 0.460 |
Why?
|
| Chickens | 2 | 2023 | 133 | 0.420 |
Why?
|
| Pia Mater | 4 | 2002 | 5 | 0.410 |
Why?
|
| Bradykinin | 2 | 2012 | 22 | 0.410 |
Why?
|
| Brain | 8 | 2020 | 1346 | 0.410 |
Why?
|
| NG-Nitroarginine Methyl Ester | 5 | 2023 | 36 | 0.410 |
Why?
|
| Serotonin | 3 | 2002 | 123 | 0.380 |
Why?
|
| Catalase | 3 | 2018 | 109 | 0.380 |
Why?
|
| Glycerol | 2 | 2020 | 28 | 0.370 |
Why?
|
| Animals, Newborn | 8 | 2005 | 343 | 0.370 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2012 | 94 | 0.370 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2020 | 31 | 0.370 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2016 | 1039 | 0.370 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 290 | 0.360 |
Why?
|
| Acetylcholine | 2 | 2012 | 73 | 0.350 |
Why?
|
| Nitroprusside | 4 | 2016 | 15 | 0.340 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2021 | 149 | 0.330 |
Why?
|
| Arginine | 2 | 2022 | 73 | 0.310 |
Why?
|
| Clonidine | 5 | 2002 | 52 | 0.310 |
Why?
|
| Glutathione Peroxidase | 2 | 2018 | 111 | 0.300 |
Why?
|
| Trypanosoma cruzi | 3 | 1994 | 149 | 0.300 |
Why?
|
| Electrocardiography | 2 | 2018 | 156 | 0.300 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 1015 | 0.290 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2016 | 1618 | 0.280 |
Why?
|
| Angiotensins | 2 | 2022 | 8 | 0.270 |
Why?
|
| Yohimbine | 5 | 1991 | 26 | 0.260 |
Why?
|
| Cerebral Hemorrhage | 2 | 1997 | 103 | 0.260 |
Why?
|
| Dioxanes | 4 | 1991 | 11 | 0.260 |
Why?
|
| Mammals | 2 | 2022 | 105 | 0.260 |
Why?
|
| Dioxins | 3 | 1990 | 8 | 0.250 |
Why?
|
| Cyclooxygenase 2 | 1 | 2005 | 104 | 0.250 |
Why?
|
| Myocardium | 2 | 2018 | 235 | 0.250 |
Why?
|
| Free Radicals | 1 | 2004 | 74 | 0.250 |
Why?
|
| Cerebral Arteries | 3 | 2000 | 24 | 0.250 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 1997 | 86 | 0.240 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 1371 | 0.230 |
Why?
|
| Isoproterenol | 4 | 2012 | 36 | 0.230 |
Why?
|
| Lysophospholipids | 3 | 2000 | 19 | 0.230 |
Why?
|
| Organometallic Compounds | 1 | 2023 | 73 | 0.230 |
Why?
|
| Endothelial Cells | 1 | 2006 | 308 | 0.230 |
Why?
|
| Anacardium | 1 | 2023 | 2 | 0.220 |
Why?
|
| Cardiovascular Agents | 2 | 2002 | 20 | 0.220 |
Why?
|
| Glycine | 1 | 2023 | 47 | 0.220 |
Why?
|
| Sympatholytics | 1 | 2002 | 14 | 0.220 |
Why?
|
| Calcium Channels, L-Type | 1 | 2002 | 20 | 0.210 |
Why?
|
| Arterioles | 6 | 2002 | 19 | 0.210 |
Why?
|
| Cells, Cultured | 5 | 2010 | 1518 | 0.210 |
Why?
|
| Microcirculation | 4 | 2006 | 37 | 0.210 |
Why?
|
| Endothelins | 3 | 1997 | 6 | 0.200 |
Why?
|
| Potassium Dichromate | 1 | 2021 | 3 | 0.200 |
Why?
|
| Lead | 1 | 2022 | 93 | 0.200 |
Why?
|
| Prostaglandins | 3 | 1997 | 27 | 0.200 |
Why?
|
| Peroxidase | 2 | 2018 | 49 | 0.190 |
Why?
|
| Heart Rate | 3 | 2018 | 253 | 0.190 |
Why?
|
| Humans | 6 | 2022 | 37093 | 0.190 |
Why?
|
| Caesalpinia | 1 | 2020 | 1 | 0.190 |
Why?
|
| Immune System | 1 | 2021 | 41 | 0.190 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2002 | 162 | 0.190 |
Why?
|
| Genome, Viral | 1 | 2021 | 109 | 0.180 |
Why?
|
| Angiotensin II | 1 | 2020 | 97 | 0.180 |
Why?
|
| Leukotriene C4 | 2 | 2000 | 6 | 0.180 |
Why?
|
| Cocaine | 1 | 2002 | 232 | 0.180 |
Why?
|
| Calcium | 3 | 2002 | 480 | 0.180 |
Why?
|
| Immunohistochemistry | 2 | 2023 | 893 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2021 | 157 | 0.170 |
Why?
|
| Cyclic AMP | 5 | 2003 | 131 | 0.170 |
Why?
|
| Protein Carbonylation | 1 | 2018 | 8 | 0.170 |
Why?
|
| Abrus | 1 | 2018 | 1 | 0.170 |
Why?
|
| Glutathione Reductase | 1 | 2018 | 23 | 0.170 |
Why?
|
| Troponin I | 1 | 2018 | 18 | 0.170 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 143 | 0.160 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2018 | 47 | 0.160 |
Why?
|
| Xanthine Oxidase | 1 | 2018 | 8 | 0.160 |
Why?
|
| PPAR gamma | 1 | 2018 | 53 | 0.160 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2010 | 67 | 0.160 |
Why?
|
| Creatine Kinase | 1 | 2018 | 20 | 0.160 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 62 | 0.150 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2017 | 5 | 0.150 |
Why?
|
| Alanine Transaminase | 1 | 2017 | 30 | 0.150 |
Why?
|
| Neutrophil Infiltration | 1 | 2017 | 27 | 0.150 |
Why?
|
| Injections, Intraperitoneal | 1 | 2017 | 60 | 0.150 |
Why?
|
| Naphthalenes | 2 | 2010 | 38 | 0.150 |
Why?
|
| Bilirubin | 1 | 2017 | 17 | 0.150 |
Why?
|
| Alkaline Phosphatase | 1 | 2017 | 50 | 0.150 |
Why?
|
| Random Allocation | 1 | 2017 | 139 | 0.150 |
Why?
|
| Kidney Cortex | 1 | 2016 | 8 | 0.140 |
Why?
|
| Nitrites | 1 | 2016 | 46 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 121 | 0.140 |
Why?
|
| Drinking | 1 | 2016 | 38 | 0.140 |
Why?
|
| Ascorbic Acid | 2 | 2007 | 66 | 0.140 |
Why?
|
| Receptors, Adrenergic, alpha | 3 | 1992 | 18 | 0.130 |
Why?
|
| Brain Diseases | 1 | 1995 | 32 | 0.130 |
Why?
|
| Ionomycin | 1 | 1994 | 10 | 0.120 |
Why?
|
| Body Weight | 1 | 2016 | 434 | 0.120 |
Why?
|
| Calmodulin | 1 | 1994 | 46 | 0.120 |
Why?
|
| Adenosylmethionine Decarboxylase | 1 | 1993 | 1 | 0.120 |
Why?
|
| Deoxyadenosines | 1 | 1993 | 9 | 0.120 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 2 | 2005 | 11 | 0.110 |
Why?
|
| Neurons | 1 | 2020 | 1175 | 0.110 |
Why?
|
| Drug Combinations | 2 | 2005 | 98 | 0.110 |
Why?
|
| Sus scrofa | 1 | 2010 | 19 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2010 | 41 | 0.090 |
Why?
|
| Microvessels | 1 | 2010 | 28 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2012 | 353 | 0.090 |
Why?
|
| Rabbits | 6 | 1992 | 283 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 433 | 0.080 |
Why?
|
| Muscle Contraction | 1 | 2007 | 66 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 130 | 0.070 |
Why?
|
| Idazoxan | 4 | 1991 | 10 | 0.070 |
Why?
|
| Indomethacin | 2 | 1997 | 28 | 0.070 |
Why?
|
| Radioimmunoassay | 1 | 2005 | 65 | 0.070 |
Why?
|
| Arachidonic Acid | 1 | 2005 | 35 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2005 | 150 | 0.070 |
Why?
|
| Dinoprostone | 1 | 2005 | 63 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2005 | 141 | 0.060 |
Why?
|
| Xanthine | 1 | 2004 | 3 | 0.060 |
Why?
|
| Time Factors | 3 | 1996 | 1742 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2004 | 550 | 0.060 |
Why?
|
| Necrosis | 1 | 2023 | 49 | 0.060 |
Why?
|
| Chlorides | 1 | 2023 | 56 | 0.060 |
Why?
|
| Glucose | 1 | 2004 | 230 | 0.050 |
Why?
|
| Cobalt | 1 | 2022 | 26 | 0.050 |
Why?
|
| Acetylcholinesterase | 1 | 2023 | 55 | 0.050 |
Why?
|
| Intracellular Membranes | 1 | 2002 | 38 | 0.050 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 58 | 0.050 |
Why?
|
| Proteins | 1 | 2005 | 369 | 0.050 |
Why?
|
| Autonomic Nervous System | 1 | 2002 | 33 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2023 | 73 | 0.050 |
Why?
|
| Fetus | 1 | 2002 | 105 | 0.050 |
Why?
|
| Birth Weight | 1 | 2002 | 90 | 0.050 |
Why?
|
| Calcium Signaling | 1 | 2002 | 101 | 0.050 |
Why?
|
| Binding Sites | 4 | 1992 | 651 | 0.050 |
Why?
|
| Cell Line | 2 | 1994 | 1354 | 0.040 |
Why?
|
| Plant Bark | 1 | 2018 | 8 | 0.040 |
Why?
|
| Gentamicins | 1 | 2018 | 10 | 0.040 |
Why?
|
| Creatinine | 1 | 2018 | 103 | 0.040 |
Why?
|
| Inflammation | 1 | 2023 | 618 | 0.040 |
Why?
|
| Pregnancy | 1 | 2002 | 1549 | 0.040 |
Why?
|
| Iloprost | 1 | 1996 | 1 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1997 | 112 | 0.040 |
Why?
|
| Blood Vessels | 1 | 1996 | 34 | 0.040 |
Why?
|
| Drug Synergism | 1 | 1997 | 177 | 0.030 |
Why?
|
| Peptides, Cyclic | 1 | 1996 | 29 | 0.030 |
Why?
|
| Leukotrienes | 1 | 1994 | 4 | 0.030 |
Why?
|
| Egtazic Acid | 1 | 1994 | 13 | 0.030 |
Why?
|
| Aminoquinolines | 1 | 1994 | 14 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1994 | 58 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 1994 | 181 | 0.030 |
Why?
|
| Norepinephrine | 2 | 1991 | 110 | 0.030 |
Why?
|
| Eflornithine | 1 | 1992 | 18 | 0.030 |
Why?
|
| Agmatine | 1 | 1992 | 17 | 0.030 |
Why?
|
| Kinetics | 2 | 1991 | 708 | 0.030 |
Why?
|
| Cell Division | 1 | 1992 | 307 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1992 | 144 | 0.020 |
Why?
|
| Imidazoles | 1 | 1991 | 126 | 0.020 |
Why?
|
| Amitriptyline | 1 | 1990 | 9 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1990 | 34 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1990 | 31 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1993 | 935 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 1990 | 140 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1988 | 62 | 0.020 |
Why?
|
| Down-Regulation | 1 | 1990 | 435 | 0.020 |
Why?
|
| Aorta, Thoracic | 1 | 2003 | 28 | 0.010 |
Why?
|
| Female | 1 | 2002 | 20969 | 0.010 |
Why?
|
| Guanabenz | 2 | 1992 | 3 | 0.010 |
Why?
|
| Oxazoles | 2 | 1992 | 19 | 0.010 |
Why?
|
| Binding, Competitive | 2 | 1991 | 111 | 0.010 |
Why?
|
| Blood Physiological Phenomena | 1 | 1995 | 4 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 1995 | 13 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1995 | 7 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1995 | 27 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1995 | 77 | 0.010 |
Why?
|
| Cisterna Magna | 1 | 1992 | 2 | 0.010 |
Why?
|
| Infusion Pumps | 1 | 1992 | 3 | 0.010 |
Why?
|
| Osmosis | 1 | 1992 | 8 | 0.010 |
Why?
|
| Injections | 1 | 1992 | 35 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1992 | 66 | 0.010 |
Why?
|
| Parasympathetic Nervous System | 1 | 1991 | 8 | 0.010 |
Why?
|
| Sympathetic Nervous System | 1 | 1991 | 74 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1990 | 91 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1990 | 135 | 0.010 |
Why?
|